A new accelerated vaccination schedule for rapid protection against hepatitis A and B. (Q39309969)

10 September 2017

title

A new accelerated vaccination schedule for rapid protection against hepatitis A and B. (English)

1 reference

10 September 2017

1 reference

Nothdurft HD

1 reference

10 September 2017

Dietrich M

1 reference

10 September 2017

Zuckerman JN

1 reference

10 September 2017

Knobloch J

1 reference

10 September 2017

Kern P

1 reference

10 September 2017

Vollmar J

1 reference

10 September 2017

Sänger R

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

issue

7-8

1 reference

10 September 2017

page(s)

1157-1162

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

10 September 2017

1 reference

7 January 2021

Vaccination of travelers against hepatitis A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

The first combined vaccine against hepatitis A and B: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Accelerated Schedule for Hepatitis B Immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Hepatitis B vaccination with short dose intervals--a possible alternative for post-exposure prophylaxis?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Three-week hepatitis B vaccination provides protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Combined vaccination against yellow fever and typhoid fever: a comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers" vaccines with the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900432-7

7 January 2021

10.1016/S0264-410X(01)00432-7

Identifiers

DOI

1 reference

10 September 2017

1 reference